Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) Shares Outstanding (Diluted Average): 2023-2024

Historic Shares Outstanding (Diluted Average) for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $15.0 million.

  • Inhibrx Biosciences' Shares Outstanding (Diluted Average) rose 0.06% to $15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year increase of 0.06%. This contributed to the annual value of $15.0 million for FY2024, which is 27.17% up from last year.
  • Latest data reveals that Inhibrx Biosciences reported Shares Outstanding (Diluted Average) of $15.0 million as of FY2024, which was up 27.17% from $11.8 million recorded in FY2023.
  • Over the past 5 years, Inhibrx Biosciences' Shares Outstanding (Diluted Average) peaked at $15.0 million during FY2024, and registered a low of $11.8 million during FY2023.
  • Its 2-year average for Shares Outstanding (Diluted Average) is $13.4 million, with a median of $13.4 million in 2023.
  • Data for Inhibrx Biosciences' Shares Outstanding (Diluted Average) shows a peak YoY increased of 27.17% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Shares Outstanding (Diluted Average) stood at $11.8 million in 2023, then grew by 27.17% to $15.0 million in 2024.